935252-95-2

Upstream product

• 96930-18-6 (4R,5S)-4-methyl-3-pent-4-enoyl-5-phenyloxazolidin-2-one 
• 39716-58-0 pent-4-enoyl chloride 
• 935252-94-1 3-{2-[2-(tert-butyl-diphenyl-silanyloxy)-1-hydroxy-ethyl]-pent-4-enoyl}-4-methyl-5-phenyl-oxazolidin-2-one 

Downstream Products

• 171924-81-5 2,2-Dimethyl-propionic acid (1R,3R,3aS,6S,6aR)-6-(tert-butyl-diphenyl-silanyloxymethyl)-3-isopropyl-3-methoxy-3a-methyl-4-oxo-tetrahydro-furo[3,4-c]furan-1-ylmethyl ester 
• 171924-83-7 (1S,4S,5R,6R,8R)-4-<(tert-butyldiphenylsiloxy)methyl>-6-(hydroxymethyl)-8-isopropyl-8-methoxy-1-methyl-3,7-dioxabicyclo<3.3.0>octan-2-one 
• 935253-00-2 benzoic acid 4-(tert-butyl-diphenyl-silanyloxy)-2-(1,4-dioxa-spiro[4.5]dec-2-yl)-butyl ester 
• 935252-92-9 tert-butyl-[3-(1,4-dioxa-spiro[4.5]dec-2-yl)-3-(3-iodomethyl-oxiranyl)-propoxy]-diphenyl-silane 
• 935253-04-6 {3-[3-(tert-butyl-diphenyl-silanyloxy)-1-(1,4-dioxa-spiro[4.5]dec-2-yl)-propyl]-oxiranyl}-methanol 
• 935253-03-5 6-(tert-butyl-diphenyl-silanyloxy)-4-(1,4-dioxa-spiro[4.5]dec-2-yl)-hex-2-enoic acid methyl ester 
• 935252-93-0 6-(tert-butyl-diphenyl-silanyloxy)-4-(1,4-dioxa-spiro[4.5]dec-2-yl)-hex-2-en-1-ol 
• 935253-05-7 6-(tert-butyl-diphenyl-silanyloxy)-4-(1,4-dioxa-spiro[4.5]dec-2-yl)-hex-1-en-3-ol 
• 935253-01-3 4-(tert-butyl-diphenyl-silanyloxy)-2-(1,4-dioxa-spiro[4.5]dec-2-yl)-butan-1-ol 
• 935253-02-4 4-(tert-butyl-diphenyl-silanyloxy)-2-(1,4-dioxa-spiro[4.5]dec-2-yl)-butyraldehyde 
• 935252-99-6 benzoic acid 2-(1,4-dioxa-spiro[4.5]dec-2-yl)-4-hydroxy-butyl ester 
• 935252-98-5 benzoic acid 2-(1,4-dioxa-spiro[4.5]dec-2-yl)-pent-4-enyl ester 

Relevant academic research and scientific papers

Asymmetric total synthesis and formal total synthesis of the antitumor sesquiterpenoid (+)-eremantholide A

Figure presented A new asymmetric total synthesis of (+)-eremantholide A is reported in which a Hoveyda-Grubbs ring-closing metathesis (RCM) reaction is used to assemble the nine-membered oxonin ring, and an enolate alkylation between the 3(2H)-furanone 2